Faron Pharmaceuticals Oy (FARN) — Cash Flow Reinvestment Rate
Latest as of January 2015:
0.21x
Faron Pharmaceuticals Oy (FARN) has a Cash Flow Reinvestment Rate of 0.21x as of January 2015, reinvesting GBX38.00 (capex GBX38.00 ) from operating cash flow of GBX178.50. Explore cash efficiency ratio of Faron Pharmaceuticals Oy to assess how effectively this company generates cash.
Reinvestment Rate
0.21x
(Capex + Investments) / Operating CF
Total Reinvested
GBX38.00
Capex + Investments
Operating Cash Flow
GBX178.50
GBX
Capital Expenditures
GBX38.00
GBX
Annual Cash Flow Reinvestment Rate for Faron Pharmaceuticals Oy (None–None)
Year-by-year capital reinvestment analysis for Faron Pharmaceuticals Oy. For live market cap and broader valuation context, see FARN market cap overview.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow